Luye Pharma Group (HK:2186) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Luye Pharma Group has successfully completed the issuance of US$100 million in convertible bonds at a 5.85% interest rate, due in 2025. This move aims to enhance the company’s liquidity and replace short-term loans, improving its debt maturity profile. The bonds are set to be listed on the Singapore Exchange on November 1, 2024.
For further insights into HK:2186 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue